These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29976867)

  • 1. Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation-The Example of FimH.
    Krammer EM; de Ruyck J; Roos G; Bouckaert J; Lensink MF
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29976867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Tract Infection: Which Conformation of the Bacterial Lectin FimH Is Therapeutically Relevant?
    Mayer K; Eris D; Schwardt O; Sager CP; Rabbani S; Kleeb S; Ernst B
    J Med Chem; 2017 Jul; 60(13):5646-5662. PubMed ID: 28471659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex.
    Wellens A; Garofalo C; Nguyen H; Van Gerven N; Slättegård R; Hernalsteens JP; Wyns L; Oscarson S; De Greve H; Hultgren S; Bouckaert J
    PLoS One; 2008 Apr; 3(4):e2040. PubMed ID: 18446213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli.
    Tchesnokova V; Aprikian P; Kisiela D; Gowey S; Korotkova N; Thomas W; Sokurenko E
    Infect Immun; 2011 Oct; 79(10):3895-904. PubMed ID: 21768279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H
    Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Aglycone π-Stacking Yields Nanomolar to Sub-nanomolar FimH Antagonists.
    Schönemann W; Cramer J; Mühlethaler T; Fiege B; Silbermann M; Rabbani S; Dätwyler P; Zihlmann P; Jakob RP; Sager CP; Smieško M; Schwardt O; Maier T; Ernst B
    ChemMedChem; 2019 Apr; 14(7):749-757. PubMed ID: 30710416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catch-bond mechanism of the bacterial adhesin FimH.
    Sauer MM; Jakob RP; Eras J; Baday S; Eriş D; Navarra G; Bernèche S; Ernst B; Maier T; Glockshuber R
    Nat Commun; 2016 Mar; 7():10738. PubMed ID: 26948702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin.
    Touaibia M; Krammer EM; Shiao TC; Yamakawa N; Wang Q; Glinschert A; Papadopoulos A; Mousavifar L; Maes E; Oscarson S; Vergoten G; Lensink MF; Roy R; Bouckaert J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28671638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RMSD analysis of structures of the bacterial protein FimH identifies five conformations of its lectin domain.
    Magala P; Klevit RE; Thomas WE; Sokurenko EV; Stenkamp RE
    Proteins; 2020 Apr; 88(4):593-603. PubMed ID: 31622514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH.
    Wellens A; Lahmann M; Touaibia M; Vaucher J; Oscarson S; Roy R; Remaut H; Bouckaert J
    Biochemistry; 2012 Jun; 51(24):4790-9. PubMed ID: 22657089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.
    Bouckaert J; Mackenzie J; de Paz JL; Chipwaza B; Choudhury D; Zavialov A; Mannerstedt K; Anderson J; Piérard D; Wyns L; Seeberger PH; Oscarson S; De Greve H; Knight SD
    Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based drug design and optimization of mannoside bacterial FimH antagonists.
    Han Z; Pinkner JS; Ford B; Obermann R; Nolan W; Wildman SA; Hobbs D; Ellenberger T; Cusumano CK; Hultgren SJ; Janetka JW
    J Med Chem; 2010 Jun; 53(12):4779-92. PubMed ID: 20507142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation.
    Schwartz DJ; Kalas V; Pinkner JS; Chen SL; Spaulding CN; Dodson KW; Hultgren SJ
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15530-7. PubMed ID: 24003161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdomain interaction in the FimH adhesin of Escherichia coli regulates the affinity to mannose.
    Aprikian P; Tchesnokova V; Kidd B; Yakovenko O; Yarov-Yarovoy V; Trinchina E; Vogel V; Thomas W; Sokurenko E
    J Biol Chem; 2007 Aug; 282(32):23437-46. PubMed ID: 17567583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections.
    Mousavifar L; Touaibia M; Roy R
    Acc Chem Res; 2018 Nov; 51(11):2937-2948. PubMed ID: 30289687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemicals As Uropathognic Escherichia Coli FimH Antagonist: In Vitro And In Silico Approach.
    Jaiswal SK; Sharma NK; Bharti SK; Krishnan S; Kumar A; Prakash O; Kumar P; Kumar A; Gupta AK
    Curr Mol Med; 2018; 18(9):640-653. PubMed ID: 30608041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Bacterial Fimbria-Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression.
    Day CJ; Lo AW; Hartley-Tassell LE; Argente MP; Poole J; King NP; Tiralongo J; Jennings MP; Schembri MA
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactive conformation enhances binding function in physiological conditions.
    Yakovenko O; Tchesnokova V; Sokurenko EV; Thomas WE
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9884-9. PubMed ID: 26216967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.
    Sivignon A; Yan X; Alvarez Dorta D; Bonnet R; Bouckaert J; Fleury E; Bernard J; Gouin SG; Darfeuille-Michaud A; Barnich N
    mBio; 2015 Nov; 6(6):e01298-15. PubMed ID: 26578673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Integrated Way for Deciphering the Glycan Code for the FimH Lectin.
    Dumych T; Bridot C; Gouin SG; Lensink MF; Paryzhak S; Szunerits S; Blossey R; Bilyy R; Bouckaert J; Krammer EM
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30373288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.